Abstract
Enveloped viruses rely on fusion proteins in their envelope to fuse the viral membrane to the host-cell membrane. This key step in viral entry delivers the viral genome into the cytoplasm for replication. Although class II fusion proteins are genetically and structurally unrelated to class I fusion proteins, they use the same physical principles and topology as other fusion proteins to drive membrane fusion. Exposure of a fusion loop first allows it to insert into the host-cell membrane. Conserved hydrophobic residues in the fusion loop act as an anchor, which penetrates only partway into the outer bilayer leaflet of the host-cell membrane. Subsequent folding back of the fusion protein on itself directs the C-terminal viral transmembrane anchor towards the fusion loop. This fold-back forces the host-cell membrane (held by the fusion loop) and the viral membrane (held by the C-terminal transmembrane anchor) against each other, resulting in membrane fusion. In class II fusion proteins, the fold-back is triggered by the reduced pH of an endosome, and is accompanied by the assembly of fusion protein monomers into trimers. The fold-back occurs by domain rearrangement rather than by an extensive refolding of secondary structure, but this domain rearrangement and the assembly of monomers into trimers together bury a large surface area. The energy that is thus released exerts a bending force on the apposed viral and cellular membranes, causing them to bend towards each other and, eventually, to fuse.
Chapter PDF
References
Lindenbach BD, Rice CM. Flaviviridae: The viruses and their replication. In: Knipe DM, Howley PM, eds. Fields Virology. 4th ed. Philadelphia: Lippincott Williams and Wilkins, 2001:991–1041.
Schlesinger S, Schlesinger MJ. Togaviridae: The viruses and their replication. In: Knipe DM, Howley PM, eds. Fields Virology. 4th ed. Philadelphia: Lippincott Williams and Wilkins, 2001:895–916.
Kuzmin PI, Zimmerberg J, Chizmadzhev YA et al. A quantitative model for membrane fusion based on low-energy intermediates. Proc Natl Acad Sci USA 2001; 98(13):7235–7240.
Kozlov MM, Chernomordik LV. A mechanism of protein-mediated fusion: Coupling between refolding of the influenza hemagglutinin and lipid rearrangements. Biophys J 1998; 75(3): 1384–1396.
Baker KA, Dutch RE, Lamb RA et al. Structural basis for paramyxovirus-mediated membrane fusion. Mol Cell 1999;3(3):309–319.
Melikyan GB, Markosyan RM, Hemmati H et al. Evidence that the transition of HIV-1 gp41 into a six-helix bundle, not the bundle configuration, induces membrane fusion. J Cell Biol 2000; 151(2):413–423.
Russell CJ, Jardetzky TS, Lamb RA. Membrane fusion machines of paramyxoviruses: Capture of intermediates of fusion. EMBO J 2001; 20(15):4024–4034.
Skehel JJ, Wiley DC. Receptor binding and membrane fusion in virus entry: The influenza hemagglutinin. Annu Rev Biochem 2000; 69:531–569.
Wilson IA, Skehel JJ, Wiley DC. Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution. Nature 1981; 289(5796):366–373.
Rey FA, Heinz FX, Mandl C et al. The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution. Nature 1995; 375(6529):291–298.
Rosenthal PB, Zhang X, Formanowski F et al. Structure of the haemagglutinin-esterase-fusion glycoprotein of influenza C virus. Nature 1998; 396(6706):92–96.
Lescar J, Roussel A, Wien MW et al. The Fusion glycoprotein shell of Semliki Forest virus: An icosahedral assembly primed for fusogenic activation at endosomal pH. Cell 2001; 105(1): 137–148.
Modis Y, Harrison SC. A ligand-binding pocket in the dengue virus envelope glycoprotein. Proc Natl Acad Sci USA 2003; 100:6986–6991.
Modis Y, Ogata S, Clements D et al. Variable surface epitopes in the crystal structure of dengue virus type 3 envelope glycoprotein. J Virol 2005; 79(2):1223–1231.
Yin HS, Wen X, Paterson RG et al. Structure of the parainfluenza virus 5 F protein in its metastable, prefusion conformation. Nature 2006; 439(7072):38–44.
Bullough PA, Hughson FM, Skehel JJ et al. Structure of influenza haemagglutinin at the pH of membrane fusion. Nature 1994; 371(6492):37–43.
Fass D, Harrison SC, Kim PS. Retrovirus envelope domain at 1.7 angstrom resolution. Nat Struct Biol 1996; 3(5):465–469.
Chan DC, Fass D, Berger JM et al. Core structure of gp41 from the HIV envelope glycoprotein. Cell 1997; 89(2):263–273.
Tan K, Liu J, Wang J et al. Atomic structure of a thermostable subdomain of HIV-1 gp41. Proc Natl Acad Sci USA 1997; 94(23):12303–12308.
Weissenhorn W, Dessen A, Harrison SC et al. Atomic structure of the ectodomain from HIV-1 gp41. Nature 1997; 387(6631):426–430.
Malashkevich VN, Chan DC, Chutkowski CT et al. Crystal structure of the simian immunodeficiency virus (SIV) gp41 core: Conserved helical interactions underlie the broad inhibitory activity of gp41 peptides. Proc Natl Acad Sci USA 1998; 95(16):9134–9139.
Caffrey M, Cai M, Kaufman J et al. Three-dimensional solution structure of the 44 kDa ectodomain of SIV gp41. EMBO J 1998; 17(16):4572–4584.
Weissenhorn W, Carfi A, Lee KH et al. Crystal structure of the Ebola virus membrane fusion subunit, GP2, from the envelope glycoprotein ectodomain. Mol Cell 1998; 2(5):605–616.
Kobe B, Center RJ, Kemp BE et al. Crystal structure of human T cell leukemia virus type 1 gp21 ectodomain crystallized as a maltose-binding protein chimera reveals structural evolution of retro viral transmembrane proteins. Proc Natl Acad Sci USA 1999; 96(8):4319–4324.
Chen J, Skehel JJ, Wiley DC. N-and C-terminal residues combine in the fusion-pH influenza hemagglutinin HA(2) subunit to form an N cap that terminates the triple-stranded coiled coil. Proc Natl Acad Sci USA 1999; 96(16):8967–8972.
Zhao X, Singh M, Malashkevich VN et al. Structural characterization of the human respiratory syncytial virus fusion protein core. Proc Natl Acad Sci USA 2000; 97(26): 14172–14177.
Xu Y, Lou Z, Liu Y et al. Crystal structure of severe acute respiratory syndrome coronavirus spike protein fusion core. J Biol Chem 2004; 279(47):49414–49419.
Xu Y, Liu Y, Lou Z et al. Structural basis for coronavirus-mediated membrane fusion. Crystal structure of mouse hepatitis virus spike protein fusion core. J Biol Chem 2004; 279(29):30514–30522.
Modis Y, Ogata S, Clements D et al. Structure of the dengue virus envelope protein after membrane fusion. Nature 2004; 427(6972):313–319.
Gething MJ, White JM, Waterfield MD. Purification of the fusion protein of Sendai virus: Analysis of the NH2-terminal sequence generated during precursor activation. Proc Natl Acad Sci USA 1978; 75(6):2737–2740.
Gallaher WR. Detection of afusionpeptide sequence in the transmembrane protein of human immunodeficiency virus. Cell 1987; 50(3):327–328.
Supekar VM, Bruckmann C, Ingallinella P et al. Structure of a proteolytically resistant core from the severe acute respiratory syndrome coronavirus S2 fusion protein. Proc Natl Acad Sci USA 2004; 101(52): 17958–17963.
Cheng SF, Wu CW, Kantchev EA et al. Structure and membrane interaction of the internal fusion peptide of avian sarcoma leukosis virus. Eur J Biochem 2004; 271(23–24):4725–4736.
Allison SL, Schalich J, Stiasny K et al. Mutational evidence for an internal fusion peptide in flavivirus envelope protein E. J Virol 2001; 75(9):4268–4275.
Zhang Y, Zhang W, Ogata S et al. Conformational changes of the flavivirus E glycoprotein. Structure (Camb) 2004; 12(9):1607–1618.
Chen Y, Maguire T, Hileman RE et al. Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate. Nat Med 1997; 3(8):866–871.
Navarro-Sanchez E, Altmeyer R, Amara A et al. Dendritic-cell-specific ICAM3-grabbing nonintegrin is essential for the productive infection of human dendritic cells by mosquito-cell-derived dengue viruses. EMBO Rep 2003; 4(7 Suppl): 1–6.
Tassaneetrithep B, Burgess TH, Granelli-Piperno A et al. DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells. J Exp Med 2003; 197(7): 823–829.
Crill WD, Roehrig JT. Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells. J Virol 2001; 75(16):7769–7773.
Hung JJ, Hsieh MT, Young MJ et al. An external loop region of domain III of dengue virus type 2 envelope protein is involved in serotype-specific binding to mosquito but not mammalian cells. J Virol 2004; 78(l):378–388.
Thepparit C, Smith DR. Serotype-specific entry of dengue virus into liver cells: Identification of the 37-kilodalton/67-kilodalton high-affinity laminin receptor as a dengue virus serotype 1 receptor. J Virol 2004; 78(22):12647–12656.
Chu JJ, Ng ML. Interaction of West Nile virus with alpha v beta 3 integrin mediates virus entry into cells. J Biol Chem 2004; 279(52):54533–54541.
Allison SL, Stiasny K, Stadler K et al. Mapping of functional elements in the stem-anchor region of tick-borne encephalitis virus envelope protein E. J Virol 1999; 73(7):5605–5612.
Stadler K, Allison SL, Schalich J et al. Proteolytic activation of tick-borne encephalitis virus by furin. J Virol 1997; 71(11):8475–8481.
Zhang Y, Corver J, Chipman PR et al. Structures of immature flavivirus particles. EMBO J 2003; 22(11):2604–2613.
Ferlenghi I, Gowen B, de Haas F et al. The first step: Activation of the Semliki Forest virus spike protein precursor causes a localized conformational change in the trimeric spike. J Mol Biol 1998; 283(1):71–81.
Kuhn RJ, Zhang W, Rossmann MG et al. Structure of dengue virus: Implications for flavivirus organization, maturation, and fusion. Cell 2002; 108(5):717–725.
Zhang W, Chipman PR, Corver J et al. Visualization of membrane protein domains by cryo-electron microscopy of dengue virus. Nat Struct Biol 2003; 10(11):907–912.
Mukhopadhyay S, Kim BS, Chipman PR et al. Structure of West Nile virus. Science 2003; 302(5643):248.
Mancini EJ, Clarke M, Gowen BE et al. Cryo-electron microscopy reveals the functional organization of an enveloped virus, Semliki Forest virus. Mol Cell 2000; 5(2):255–266.
Zhang W, Mukhopadhyay S, Pletnev SV et al. Placement of the structural proteins in Sindbis virus. J Virol 2002;76(22):11645–11658.
Elshuber S, Allison SL, Heinz FX et al. Cleavage of protein prM is necessary for infection of BHK-21 cells by tick-borne encephalitis virus. J Gen Virol 2003; 84(Pt 1):183–191.
Guirakhoo F, Heinz FX, Mandl CW et al. Fusion activity of flaviviruses: Comparison of mature and immature (prM-containing) tick-borne encephalitis virions. J Gen Virol 1991; 72(Pt 6): 1323–1329.
Guirakhoo F, Bolin RA, Roehrig JT. The Murray Valley encephalitis virus prM protein confers acid resistance to virus particles and alters the expression of epitopes within the R2 domain of E glycoprotein. Virology 1992; 191(2):921–931.
Gibbons DL, Vaney MC, Roussel A et al. Conformational change and protein-protein interactions of the fusion protein of Semliki Forest virus. Nature 2004; 427(6972):320–325.
Bressanelli S, Stiasny K, Allison SL et al. Structure of aflavivirus envelope glycoprotein in its low-pH-induced membrane fusion conformation. EMBO J 2004; 23(4):728–738.
Cecilia D, Gould EA. Nucleotide changes responsible for loss of neuroinvasiveness in Japanese encephalitis virus neutralization-resistant mutants. Virology 1991; 181(l):70–77.
Hasegawa H, Yoshida M, Shiosaka T et al. Mutations in the envelope protein of Japanese encephalitis virus affect entry into cultured cells and virulence in mice. Virology 1992; 191(1):158–165.
Lee E, Weir RC, Dalgarno L. Changes in the dengue virus major envelope protein on passaging and their localization on the three-dimensional structure of the protein. Virology 1997; 232(2):281–290.
Beasley DW, Aaskov JG. Epitopes on the dengue 1 virus envelope protein recognized by neutralizing IgM monoclonal antibodies. Virology 2001; 279(2):447–458.
Hurrelbrink RJ, McMinn PC. Attenuation of Murray Valley encephalitis virus by site-directed mutagenesis of the hinge and putative receptor-bindingregions of the envelope protein. J Virol 2001; 75(16):7692–7702.
Monath TP, Arroyo J, Levenbook I et al. Single mutation in the flavivirus envelope protein hinge region increases neurovirulence for mice and monkeys but decreases viscerotropism for monkeys: Relevance to development and safety testing of live, attenuated vaccines. J Virol 2002; 76(4): 1932–1943.
Dubovskii PV, Li H, Takahashi S et al. Structure of an analog of fusion peptide from hemagglutinin. Protein Sci 2000; 9(4):786–798.
Han X, Bushweller JH, Cafiso DS et al. Membrane structure and fusion-triggering conformational change of the fusion domain from influenza hemagglutinin. Nat Struct Biol 2001; 8(8):715–720.
Tamm LK, Han X, Li Y et al. Structure and function of membrane fusion peptides. Biopolymers 2002; 66(4):249–260.
Ruigrok RW, Aitken A, Calder LJ et al. Studies on the structure of the influenza virus haemagglutinin at the pH of membrane fusion. J Gen Virol 1988; 69(Pt 11):2785–2795.
Stiasny K, Allison SL, Schalich J et al. Membrane interactions of the tick-borne encephalitis virus fusion protein E at low pH. J Virol 2002; 76(8):3784–3790.
Chan DC, Kim PS. HIV entry and its inhibition. Cell 1998; 93(5):681–684.
Danieli T, Pelletier SL, Henis YI et al. Membrane fusion mediated by the influenza virus hemagglutinin requires the concerted action of at least three hemagglutinin trimers. J Cell Biol 1996; 133(3):559–569.
Blumenthal R, Sarkar DP, Durell S et al. Dilation of the influenza hemagglutinin fusion pore revealed by the kinetics of individual cell-cell fusion events. J Cell Biol 1996; 135(1):63–71.
Razinkov VI, Melikyan GB, Cohen FS. Hemifusion between cells expressing hemagglutinin of influenza virus and planar membranes can precede the formation of fusion pores that subsequently fully enlarge. Biophys J 1999; 77(6):3144–3151.
Kemble GW, Danieli T, White JM. Lipid-anchored influenza hemagglutinin promotes hemifusion, not complete fusion. Cell 1994; 76(2):383–391.
Melikyan GB, White JM, Cohen FS. GPI-anchored influenza hemagglutinin induces hemifusion to both red blood cell and planar bilayer membranes. J Cell Biol 1995; 131(3):679–691.
Nussler F, Clague MJ, Herrmann A. Meta-stability of the hemifusion intermediate induced by glycosylphosphatidylinositol-anchored influenza hemagglutinin. Biophys J 1997; 73(5):2280–2291.
Armstrong RT, Kushnir AS, White JM. The transmembrane domain of influenza hemagglutinin exhibits a stringent length requirement to support the hemifusion to fusion transition. J Cell Biol 2000; 151(2):425–437.
Saifee O, Wei L, Nonet ML. The Caenorhabditis elegans unc-64 locus encodes a syntaxin that interacts genetically with synaptobrevin. Mol Biol Cell 1998; 9(6):1235–1252.
McNew JA, Weber T, Parlati F et al. Close is not enough: SNARE-dependent membrane fusion requires an active mechanism that transduces force to membrane anchors. J Cell Biol 2000; 150(1): 105–117.
West JT, Johnston PB, Dubay SR et al. Mutations within the putative membrane-spanning domain of the simian immunodeficiency virus transmembrane glycoprotein define the minimal requirements for fusion, incorporation, and infectivity. J Virol 2001; 75(20):9601–9612.
Dutch RE, Lamb RA. Deletion of the cytoplasmic tail of the fusion protein of the paramyxovirus simian virus 5 affects fusion pore enlargement. J Virol 2001; 75(11):5363–5369.
Melikyan GB, Markosyan RM, Brener SA et al. Role of the cytoplasmic tail of ecotropic moloney murine leukemia virus Env protein in fusion pore formation. J Virol 2000; 74(l):447–455.
Melikyan GB, Jin H, Lamb RA et al. The role of the cytoplasmic tail region of influenza virus hemagglutinin information and growth of fusion pores. Virology 1997; 235(1):118–128.
Bagai S, Lamb RA. Truncation of the COOH-terminal region of the paramyxovirus SV5 fusion protein leads to hemifusion but not complete fusion. J Cell Biol 1996; 135(1):73–84.
Januszeski MM, Cannon PM, Chen D et al. Functional analysis of the cytoplasmic tail of Moloney murine leukemia virus envelope protein. J Virol 1997; 71(5):3613–3619.
Nieva JL, Bron R, Corver J et al. Membrane fusion of Semliki Forest virus requires sphingolipids in the target membrane. EMBO J 1994; 13(12):2797–2804.
Vashishtha M, Phalen T, Marquardt MT et al. A single point mutation controls the cholesterol dependence of Semliki Forest virus entry and exit. J Cell Biol 1998; 140(1):91–99.
Chanel-Vos C, Kielian M. A conserved histidine in the ij loop of the Semliki Forest virus E1 protein plays an important role in membrane fusion. J Virol 2004; 78(24): 13543–13552.
Chatterjee PK, Eng CH, Kielian M. Novel mutations that control the sphingolipid and cholesterol dependence of the Semliki Forest virus fusion protein. J Virol 2002; 76(24):12712–12722.
Stiasny K, Koessl C, Heinz FX. Involvement of lipids in different steps of the flavivirus fusion mechanism. J Virol 2003; 77(14):7856–7862.
Burke DS, Monath TP. Flaviviruses. In: Knipe DM, Howley PM, eds. Fields Virology. 4th ed. Philadelphia: Lippincott Williams and Wilkins, 2001:1043–1125.
Smith TJ, Kremer MJ, Luo M et al. The site of attachment in human rhinovirus 14 for antiviral agents that inhibit uncoating. Science 1986; 233(4770): 1286–1293.
Baldwin CE, Sanders RW, Berkhout B. Inhibiting HIV-1 entry with fusion inhibitors. Curr Med Chem 2003; 10(17):1633–1642.
Kilby JM, Hopkins S, Venetta TM et al. Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry. Nat Med 1998; 4(11):1302–1307.
Kanai R, Kar K, Anthony K et al. Crystal structure of west nile virus envelope glycoprotein reveals viral surface epitopes. J Virol 2006; 80(22): 11000–11008.
Nayak V, Dessau M, Kucera K et al. Crystal structure of dengue virus type 1 envelope protein in the postfusion conformation and its implications for membrane fusion. J Virol 2009; 83(9):4338–4344.
Voss JE, Vaney MC, Duquerroy S et al. Glycoprotein organization of Chikungunya virus particles revealed by X-ray crystallography. Nature 2010; 468(7324):709–712.
Li L, Jose J, Xiang Y et al. Structural changes of envelope proteins during alphavirus fusion. Nature 2010; 468(7324):705–708.
Cockburn JJ, Navarro Sanchez ME et al. Structural insights into the neutralization mechanism of a higher primate antibody against dengue virus. EMBO J 2011; 31(3):767–779.
Luca VC, AbiMansour J, Nelson CA, Fremont DH. Crystal structure of the Japanese encephalitis virus envelope protein. J Virol 2012; 86(4):2337–2346.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Landes Bioscience and Springer Science+Business Media
About this chapter
Cite this chapter
Modis, Y. (2013). Class II Fusion Proteins. In: Pöhlmann, S., Simmons, G. (eds) Viral Entry into Host Cells. Advances in Experimental Medicine and Biology, vol 790. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-7651-1_8
Download citation
DOI: https://doi.org/10.1007/978-1-4614-7651-1_8
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-7650-4
Online ISBN: 978-1-4614-7651-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)